We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.1%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$22.8B
AUM Growth
+$2.31B
Cap. Flow
+$2.06B
Cap. Flow %
9.04%
Top 10 Hldgs %
14.6%
Holding
2,473
New
253
Increased
1,354
Reduced
677
Closed
147

Top Buys

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$83.8M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$44.7M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$44M
4
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$37.8M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$33.3M

Top Sells

Rank Stock Value
1
QAI icon
NYLI Hedge Multi-Strategy Tracker ETF
QAI
+$59.4M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$31.1M
3
COP icon
ConocoPhillips
COP
+$24.4M
4
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$24.2M
5
MAT icon
Mattel
MAT
+$21.8M

Sector Composition

Rank Sector Weight
1 Healthcare 9.41%
2 Technology 8.67%
3 Financials 7.91%
4 Industrials 7.66%
5 Energy 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGRX
2251
DELISTED
Agile Therapeutics
AGRX
$253K ﹤0.01%
+14
New +$245K
HMHC
2252
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$251K ﹤0.01%
10,692
-198
-2% -$4.08K
VHI icon
2253
Valhi
VHI
$450M
$250K ﹤0.01%
3,338
-500
-13% -$35.8K
KERX
2254
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$250K ﹤0.01%
19,624
+2,235
+13% +$28.7K
PTX
2255
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$249K ﹤0.01%
+2,325
New +$222K
XNPT
2256
DELISTED
XENOPORT, INC.
XNPT
$249K ﹤0.01%
+35,000
New +$271K
IFLN
2257
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$307M
$248K ﹤0.01%
13,070
+1,576
+14% +$29.8K
VGR
2258
DELISTED
Vector Group Ltd.
VGR
$248K ﹤0.01%
20,301
+1,249
+7% +$15.5K
NPP
2259
DELISTED
NUVEEN PERFORMANCE+MUN FUND
NPP
$248K ﹤0.01%
16,669
+2,219
+15% +$33K
NPBC
2260
DELISTED
NATL PENN BANCSHARES INC
NPBC
$248K ﹤0.01%
23,034
-2,527
-10% -$26.4K
VIVS
2261
VivoSim Labs
VIVS
$1.64M
$247K ﹤0.01%
+290
New +$401K
JTA
2262
DELISTED
Nuveen Tax-Advantaged Total Return Strategy Fund
JTA
$247K ﹤0.01%
18,272
-7,887
-30% -$106K
EFC
2263
Ellington Financial
EFC
$1.71B
$245K ﹤0.01%
12,319
-460
-4% -$9.38K
NQM
2264
DELISTED
NUVEEN INVESTMENT QLTY MUNI FD
NQM
$244K ﹤0.01%
15,580
-7,161
-31% -$111K
ASG
2265
Liberty All-Star Growth Fund
ASG
$341M
$243K ﹤0.01%
46,461
+732
+2% +$3.73K
IGI
2266
Western Asset Investment Grade Defined Opportunity Trust
IGI
$94.9M
$242K ﹤0.01%
11,550
-500
-4% -$10.6K
UMH
2267
UMH Properties
UMH
$1.36B
$242K ﹤0.01%
24,058
-3,375
-12% -$32.6K
SOCB
2268
DELISTED
SOUTHCOAST FINANCIAL CORP
SOCB
$240K ﹤0.01%
33,210
-2,150
-6% -$15.4K
MSD
2269
Morgan Stanley Emerging Markets Debt Fund
MSD
$148M
$239K ﹤0.01%
+25,818
New +$238K
WSCI
2270
DELISTED
WSI Industries Inc
WSCI
$239K ﹤0.01%
40,755
+3,200
+9% +$18.8K
CVRR
2271
DELISTED
CVR Refining, LP
CVRR
$238K ﹤0.01%
11,482
-5,796
-34% -$106K
NML
2272
Neuberger Energy Infrastructure and Income Fund Inc
NML
$576M
$234K ﹤0.01%
+13,300
New +$243K
DBC icon
2273
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
$233K ﹤0.01%
13,631
-4,692
-26% -$82.6K
EHI
2274
Western Asset Global High Income Fund
EHI
$178M
$233K ﹤0.01%
20,929
-1,959
-9% -$21.8K
LVL
2275
DELISTED
Invesco S&P Global Dividend Opportunities Index ETF
LVL
$233K ﹤0.01%
20,539
-2,250
-10% -$25.9K
89 90
91
92 93

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q1 2015 Portfolio in Review

As of Q1 2015, Raymond James & Associates held 2,473 positions worth $22.8B, up 11% from $20.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $2.06B of net new capital in Q1 2015, opening 253 new positions and adding to 1,354 existing holdings. Its largest new stake was Hormel Foods: 461,564 shares worth $13.1M.

By sector, the portfolio is most concentrated in Healthcare at 9.4% of assets, up from 8.7% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was NYLI Hedge Multi-Strategy Tracker ETF, an estimated $59.4M trimmed.

  • Raymond James & Associates's largest Q1 2015 buy was Hormel Foods: 461,564 shares worth $13.1M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2015, an estimated $83.8M increase.
  • Raymond James & Associates's biggest Q1 2015 reduction was NYLI Hedge Multi-Strategy Tracker ETF, cutting an estimated $59.4M.
  • Raymond James & Associates fully exited Edgewell Personal Care in Q1 2015, selling an estimated $21.8M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $22.8B portfolio in Q1 2015.
  • Raymond James & Associates opened 253 new positions and closed 147 in Q1 2015.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $22.8B.

Based on Raymond James & Associates's 13F filing for Q1 2015, filed 28 Apr 2015.